From research to commercialization, Innovabio’s R&D has developed winning expertise in collagen peptides applications that promote health and well-being.
Innovabio’s R&D teams are focused on the following:
• improving the bioavailability of the collagen
Innovabio has developed a patent micro-encapsulated collagen allowing a better bioavailability than conventional hydrolyzed collagen.
The breakthrough innovation is the unique low molecular weight of the Innovabio Collagen (2000 Da with 30% under 1000 Da instead of 5 000 Da for conventional collagen) and its high content in tripeptides increasing its bioavailability.
Another advantage of the Innovabio patent micro-encapsulated collagen is a specific process protecting and improving the collagen in order to guarantee a better taste and stability in high dosage.
Finally by combining its innovative collagen and its patent NatCaps® micro-encapsulation technology, Innovabio has developed a unique process for incorporating sensitive micronutrients while guaranteeing a better stability during manufacturing process and storage.
• Exploring additional health benefits of Collagen peptides on Skin, Bone, Joint and Sport Nutrition.
(See Clinical Studies)
• Identifying and creating new delivery forms and commercially viable applications for the nutraceutical, pharmaceutical and functional food markets.
(See Ready-to-Market Products) and (See Private-Label Solutions)